Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian share markets open in the red
Thu, 26 Jun 09:30 am

Barring Malaysia (down 0.3%), the major Asian stock markets have opened in the green with Singapore (up 0.4%) and Hong Kong (up 0.9%) leading the gains.

However, the Indian share markets have opened the day on a negative note. Barring oil and gas, all sectoral indices have opened in the green with stocks in banking and auto sector leading the gains.

The Sensex today is down by around 22 points (0.1%), while the NSE-Nifty is down by around 7 points. The midcap and smallcap stocks have opened in the green with BSE Mid Cap and BSE Small Cap indices up by around 0.3% and 0.4% respectively. The rupee is currently trading at Rs 60.14 to the US dollar.

Auto stocks have opened the day mainly in the green with Force Motors Ltd and Eicher Motors Ltd leading the gains. However, Maruti Suzuki Ltd and Tube Investments Ltd were leading the losses. As per a leading financial daily, Ashok Leyland is planning to raise about Rs 6 to Rs 7 bn through a qualified institutional placement to pare debt. The fund raising is expected to be concluded in the next couple of weeks. As per the sources close to the company, the move may lead to the equity dilution of 6.1% in the company and may bring down promoter's stake to 39% from 41.25% in FY14. It was in August 2013 that the peak debt of the company touched Rs 62 bn. Since then, the company subsequently has been reducing its debt burden gradually through several measures. At the end of FY14, the company's debt stood at Rs 39 bn, with debt to equity ratio standing at 0.87 times, up from 0.78 times in FY13,

Indian Pharma stocks have opened the day on a mixed note with Dishman Pharma Ltd and JB Chemicals Ltd leading the gains. However, Natco Pharma Ltd and Glenmark Pharma Ltd were facing maximum selling pressure. As per a leading financial daily, the domestic Pharma sector is likely to be offered a financing scheme by the Modi government for the upgradation of manufacturing facilities and meet stringent standards of the world's leading export markets. It is important to note here that Indian pharma companies are facing a tough time on account of quality issues raised by US Food and Drug Administation (USFDA). One of the options being considered is an interest subsidy scheme for the upgradation of manufacturing facilities. Besides, the Government is also aims to boost the active ingredients segment of the domestic industry, which has suffered from cheap Chinese imports.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Indian share markets open in the red". Click here!

  

Related Views on News

ASHOK LEYLAND Announces Quarterly Results (3QFY20); Net Profit Down 92.7% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, ASHOK LEYLAND has posted a net profit of Rs 278 m (down 92.7% YoY). Sales on the other hand came in at Rs 40 bn (down 36.5% YoY). Read on for a complete analysis of ASHOK LEYLAND's quarterly results.

ASHOK LEYLAND Announces Quarterly Results (2QFY20); Net Profit Down 91.5% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, ASHOK LEYLAND has posted a net profit of Rs 389 m (down 91.5% YoY). Sales on the other hand came in at Rs 39 bn (down 48.4% YoY). Read on for a complete analysis of ASHOK LEYLAND's quarterly results.

ASHOK LEYLAND 2018-19 Annual Report Analysis (Annual Result Update)

Sep 16, 2019 | Updated on Sep 16, 2019

Here's an analysis of the annual report of ASHOK LEYLAND for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ASHOK LEYLAND. Also includes updates on the valuation of ASHOK LEYLAND.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Mar 1, 2021 03:36 PM

S&P BSE HEALTHCARE 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS